Ultra-large-Scale Biomanufacturing Empowered By Efficient Technology Transfer And Panflex System

By Chi-Ming Yu, W. Roy Lin, Peng Jiao

Biologics manufacturing is entering a new phase. As demand grows and available capacity becomes increasingly constrained, companies are looking beyond traditional in-house production models and relying more heavily on external partners for large-scale commercial manufacturing. This shift is driving the need for faster, more reliable technology transfer processes that can move programs from development into GMP manufacturing without compromising quality or timelines.

Examine the strategies that support successful technology transfer at scale, including approaches tailored to different levels of process maturity, integrated transfer workflows, and accelerated pathways to GMP and process validation readiness. It also highlights manufacturing capacity across scales ranging from 50L to 30,000L, providing perspective on how facility design and production requirements continue to evolve.

Whether scaling an established process or preparing for commercial supply, effective technology transfer can be the difference between a smooth transition and costly delays.

Explore the framework, best practices, and capacity considerations helping manufacturers meet the demands of the next generation of large-scale biologics production.